why choose us

Course: Updates and Best Practices Across Malignancies: Evaluating Therapeutic Developments and Optimizing Multidisciplinary Care in Non-Hodgkin’s Lymphoma

CME Credits: 0.00

Released: 0000-00-00

This enduring educational activity focuses on leveraging targetable mutations for cancer-directed therapy through evaluating approaches to tumor assessment as well as the latest developments in novel targeted and immune-therapeutic approaches. Learn more about potential immune targets, systemic treatment strategies, and optimizing multidisciplinary management to individualize care in Non-Hodgkin’s Lymphoma.


View Full Course